M Montorsi
Overview
Explore the profile of M Montorsi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
130
Citations
860
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mrakic-Sposta S, Gussoni M, Dellanoce C, Marzorati M, Montorsi M, Rasica L, et al.
Eur J Appl Physiol
. 2020 Oct;
121(1):297-306.
PMID: 33057877
Purpose: High altitude results in lower barometric pressure and hence partial pressure of O decrease can lead to several molecular and cellular changes, such as generation of reactive oxygen species...
2.
Spinelli A, Carvello M, Sacchi M, Bonifacio C, Bertuzzi A, Tuynman J, et al.
Tech Coloproctol
. 2019 May;
23(5):501-502.
PMID: 31037577
No abstract available.
3.
Spinelli A, Carvello M, Kotze P, Maroli A, Montroni I, Montorsi M, et al.
Colorectal Dis
. 2019 Mar;
21(7):827-832.
PMID: 30873703
Aim: An anastomotic leak in ileoanal pouch surgery may lead to pouch failure. Constructing a tension-free ileal pouch-anal anastomosis (IPAA) reduces this risk but can be technically challenging, balancing pouch...
4.
Uzunoglu F, Welte M, Gavazzi F, Maggino L, Perinel J, Salvia R, et al.
Eur J Surg Oncol
. 2018 Dec;
45(5):793-799.
PMID: 30585172
Background: The MDACC group recommends to extend the current borderline classification for pancreatic cancer into three groups: type A patients with resectable/borderline tumor anatomy, type B with resectable/borderline resectable tumor...
5.
Uccelli F, Gavazzi F, Capretti G, Virdis M, Montorsi M, Zerbi A
Updates Surg
. 2016 Oct;
68(3):313-319.
PMID: 27709476
Enucleation (EN) and middle pancreatectomy (MP) have been proposed as a treatment for G1 and G2 pancreatic neuroendocrine tumors (PNET). The aim of this study is to analyze the outcomes...
6.
de Nes L, Bacchelli C, Montorsi M, Spinelli A
Colorectal Dis
. 2015 Nov;
18(2):215.
PMID: 26588201
No abstract available.
7.
De Nes L, Montorsi M, Spinelli A
Colorectal Dis
. 2015 Nov;
18(2):217-8.
PMID: 26559039
No abstract available.
8.
Nobaek S, Rogmark P, Petersson U, Hu S, Sun P, Song Z, et al.
Hernia
. 2015 Nov;
19 Suppl 1:S51-6.
PMID: 26518861
No abstract available.
9.
Malesci A, Basso G, Bianchi P, Fini L, Grizzi F, Celesti G, et al.
Br J Cancer
. 2014 Jan;
110(5):1228-35.
PMID: 24434431
Background: It is uncertain whether synchronous colorectal cancers (S-CRCs) preferentially develop through widespread DNA methylation and whether they have a prognosis worse than solitary CRC. As tumours with microsatellite instability...
10.
Celesti G, Di Caro G, Bianchi P, Grizzi F, Marchesi F, Basso G, et al.
Br J Cancer
. 2013 Oct;
109(9):2424-33.
PMID: 24084767
Background: In pancreatic ductal adenocarcinoma (PDAC), fractalkine receptor CX3CR1 contributes to perineural invasion (PNI). We investigated whether CX3CR1 expression occurs early in PDAC and correlates with tumour features other than...